The Novartis COVID-19 response fund is set to provide $20m in grants to support public health initiatives to help communities manage the challenges posed by the pandemic.
As outbreaks across the world are unfolding at a rapid pace, Novartis has established a fast-track review process that will allow for quick approval and disbursement of grants worth up to $1m.
The Swiss pharma has outlined a rough guideline for potential initiatives that would qualify for a financial grant – although it is not limited to specific areas.
That includes initiatives focused on strengthening local and national healthcare infrastructure, establishing digital platforms for COVID-19 related data collection, remote delivery of healthcare and effective dissemination of crucial public health information.
It will also look to provide grants for initiatives focused on creating new or enhancing new community health programmes specific to the pandemic response.